Analyst Ratings for Ligand Pharma (LGND)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/22/2011 | Griffin Securities | N/A | New Coverage | Buy (N/A) |
18.00 (N/A) |
10.59 (12.22) |
15.39% | Details |
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/22/2011 | Griffin Securities | N/A | New Coverage | Buy (N/A) |
18.00 (N/A) |
10.59 (12.22) |
15.39% | Details |
